GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
NYSE:MSTX
Delisted

Mast Therapeutics, Inc Fund Predictions

$0.130
+0 (+0%)
At Close: Jan 16, 2018
Currently predicting for Mon, 22 Apr 2024

MSTX Predictions History

6 years ago
Michael.Moore.6256 predicted that MSTX for 2017-05-01 is going $0.480 (266.41%)

Rank:

6 years ago
Andy predicted that MSTX for 2017-05-01 is going $0.0100 (-92.37%)

Rank:

6 years ago
JS predicted that MSTX for 2017-04-28 is going $0.130 (-0.76%)

6 years ago
Michael.Moore.6256 predicted that MSTX for 2017-04-28 is going $0.240 (83.21%)

Rank:

6 years ago
AJR predicted that MSTX for 2017-04-28 is going $0.128 (-2.29%)

Rank:

6 years ago
Andy predicted that MSTX for 2017-04-28 is going $0.0100 (-92.37%)

Rank:

6 years ago
JuanC Villegas predicted that MSTX for 2017-04-28 is going $0.140 (6.87%)

6 years ago
warrior.trader.6102 predicted that MSTX for 2017-04-25 is going $0.154 (11.59%)

Rank:

6 years ago
Andy predicted that MSTX for 2017-04-25 is going $0.143 (3.62%)

Rank:

6 years ago
Andy predicted that MSTX for 2017-04-24 is going $0.150 (15.38%)

Rank:
Click to get the best stock tips daily for free!

About Mast Therapeutics, Inc

Mast Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for serious or life-threatening diseases with significant unmet needs. The company’s lead product candidate is MST-188 (vepoloxamer), an injection used for the treatment of sickle cell disease, arterial disease, and heart failure. It also develops AIR001, a sodium nitrite solution for intermittent inhalation via nebulizer, as well as for the treatment of hear... MSTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT